Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

Kristin A Rand, PhD, M.P.H., Chi Song, M.S., Amie E. Hwang, PhD, M.P.H., Carol A. Huff, MD, Leon Bernal-Mizrachi, MD, Michael H Tomasson, MD, Sikander Ailawadhi, MD, David J. Van Den Berg, PhD, Xin Sheng, PhD, John J. Graff, PhD, M.S., David V. Conti, PhD, Todd Zimmerman, MD, Edward Peters, D.MD S.M, Sc.D., Seema Singhal, MD, Cathryn H. Bock, PhD, Karen Pawlish, M.P.H., Graham A Colditz, MD, Dr.PH., Xin Sheng, PhD, Alexander Stram, M.S., Sara S. Strom, PhD, Benjamin Rybicki, PhD, Rick Kittles, PhD, Howard Terebelo, DO, Janet Stanford, PhD, MPH, Phyllis J. Goodman, PhD, Sonja I Berndt, PhD, John Carpten, PhD, Anselm JM Hennis, MSc,PhD MRCP, FRCP, Lisa Chu, PhD, M.P.H., Graham Casey, PhD, W R Driver, MSPH, Eric A. Klein, MD, M. Christina Leske, MD MPH, Esther John, PhD, Adam Bryant Murphy, MD, Christine Neslund-Dudas, PhD, Victoria L. Stevens, PhD, Curtis Pettaway, MD, Wei Zheng, MD PhD MPH, Suh-Yuh Wu, M.A., John Witte, PhD, Siqun Lilly Zheng, MD, Jianfeng Xu, MD,Dr.PH, Nikhil C. Munshi, MD, Ann Hsing, PhD, Sue Ingles, PhD, Jayesh Mehta, MD, Lisa B. Signorello, PhD, Stephen Jacob Chanock, MD, Barbara Nemesure, PhD, Ann M Mohrbacher, MD, Nalini Janakiraman, MD, William J Blot, MD, Brian E. Henderson, MD, Laurence N. Kolonel, MD PhD, Kenneth C. Anderson, MD, Brian C-H Chiu, PhD, Jeffrey Zonder, MD, Robert Z. Orlowski, PhD MD, Sagar Lonial, MD, Daniel O. Stram, PhD, Christopher Haiman, Sc.D., Wendy Cozen, DO, MPH

Blood (2014) 124 (21): 2030.

https://doi.org/10.1182/blood.V124.21.2030.2030

Published: 2014

Journal Articles

Other Cancers in Long-Term Survivors of Chronic Lymphocytic Leukemia: Incidence and Prognostic Relevance

Lorenzo Falchi, MD, Michael Keating, MBBS, Susan Lerner, MS, Xuemei Wang, PhD, Kplola Y Elhor Gbito, MD MPH, Sara S. Strom, PhD, William G. Wierda, MD PhD, Alessandra Ferrajoli, MD

Blood (2014) 124 (21): 3323.

https://doi.org/10.1182/blood.V124.21.3323.3323

Published: 2014

Journal Articles

Chronic Myeloid Leukemia in Chronic Phase: Survival in the Era of Tyrosine Kinase Inhibitors Is Similar to That of the General Population in All Age Groups

Koji Sasaki, Sara S. Strom, PhD, Susan O'Brien, MD, Elias Jabbour, MD, Farhad Ravandi, MD, Marina Konopleva, MD PhD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Naval Daver, MD, Sherry R. Pierce, RN, BS, Hagop M. Kantarjian, MD, Jorge E. Cortes

Blood (2014) 124 (21): 1801.

https://doi.org/10.1182/blood.V124.21.1801.1801

Published: 2014

Journal Articles

Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases

Katarina Sevcikova, MD, Zuo Zhuang, MD PhD, Guillermo Garcia-Manero, MD, Ricardo Alvarez, MD, Hagop M. Kantarjian, MD, Mego Michal, MD, Constance Albarracin, MD PhD, Guilin Tang, MD, Sara S. Strom, PhD, James M. Reuben, PhD, Joseph D Khoury, MD

Blood (2014) 124 (21): 962.

https://doi.org/10.1182/blood.V124.21.962.962

Published: 2014

Journal Articles

Other Cancers in Patients with Chronic Lymphocytic Leukemia Requiring Therapy: Association with Prognostic Factors and Impact On Survival

Lorenzo Falchi, MD, Michael J. Keating, MD, Susan Lerner, MS, Xuemei Wang, MS, Sara S. Strom, PhD, William G. Wierda, MD, Alessandra Ferrajoli, M.D.

Blood (2012) 120 (21): 3896.

https://doi.org/10.1182/blood.V120.21.3896.3896

Published: 2012

Journal Articles

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Blood (2009) 114 (22): 1232.

https://doi.org/10.1182/blood.V114.22.1232.1232

Published: 2009

Journal Articles

Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology.

Mark C Lanasa, MD, PhD, Sallie D Allgood, MS, Susan L Slager, PhD, Nicola J Camp, PhD, Neil E. Kay, MD, Logan G Spector, PhD, Laura Z. Rassenti, PhD, Curtis A. Hanson, MD, Jon P Gockerman, MD, Barbara K Goodman, PhD, Sara S Strom, PhD, Timothy G Call, MD, James R Cerhan, MD, PhD, Jose Leis, MD, Gerald Marti, MD, PhD, Lynn Goldin, PhD, J. Brice Weinberg, Neil E Caporaso, MD

Blood (2009) 114 (22): 1241.

https://doi.org/10.1182/blood.V114.22.1241.1241

Published: 2009

Journal Articles

First Report of National Estimates of the Incidence of Myelodysplastic Syndromes and Chronic Myeloproliferative Disorders from the U.S. SEER Program.

Dana E. Rollison, PhD, Matthew Hayat, PhD, Martyn Smith, PhD, Sara S. Strom, PhD, William D. Merritt, PhD, Lynn Ries, MS, Brenda K. Edwards, PhD, Alan F. List, MD

Blood (2006) 108 (11): 247.

https://doi.org/10.1182/blood.V108.11.247.247

Published: 2006

Journal Articles

Second Cancers after CLL Diagnosis.

Yun Gu, MS, Sara S. Strom, PhD, Susan Lerner, MS, Michael J. Keating, MD

Blood (2004) 104 (11): 18.

https://doi.org/10.1182/blood.V104.11.18.18

Published: 2004

Journal Articles

Risk Factors of Myelodysplastic Syndromes (MDS): A Case-Control Study.

Sara S. Strom, PhD, Yun Gu, MS, Stephen K. Gruschkus, MPH, Elihu H. Estey, MD

Blood (2004) 104 (11): 71.

https://doi.org/10.1182/blood.V104.11.71.71

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

Other Cancers in Long-Term Survivors of Chronic Lymphocytic Leukemia: Incidence and Prognostic Relevance

Chronic Myeloid Leukemia in Chronic Phase: Survival in the Era of Tyrosine Kinase Inhibitors Is Similar to That of the General Population in All Age Groups

Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases

Other Cancers in Patients with Chronic Lymphocytic Leukemia Requiring Therapy: Association with Prognostic Factors and Impact On Survival

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology.

First Report of National Estimates of the Incidence of Myelodysplastic Syndromes and Chronic Myeloproliferative Disorders from the U.S. SEER Program.

Second Cancers after CLL Diagnosis.

Risk Factors of Myelodysplastic Syndromes (MDS): A Case-Control Study.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only